Rigid Esophagoscopy Has Low Utility in Staging for Head and Neck Cancer

Share this content:
Rigid esophagoscopy for evaluation of patients with head and neck squamous cell carcinoma is safe but has low utility for cancer staging and detection of nonmalignant esophageal disease
Rigid esophagoscopy for evaluation of patients with head and neck squamous cell carcinoma is safe but has low utility for cancer staging and detection of nonmalignant esophageal disease

Rigid esophagoscopy for evaluation of patients with head and neck squamous cell carcinoma (HNSCC) is safe but has low utility for cancer staging and detection of nonmalignant esophageal disease, according to a study published in JAMA Otolaryngology – Head & Neck Surgery.1

Researchers led by Patrick McGarey Jr, MD, of the University of Virginia Health System conducted a retrospective study of 582 patients who had undergone rigid esophagoscopy for HNSCC staging from July 2004 to October 2012.

A literature review was performed and the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database was queried in order to assess for incidence of synchronous esophageal malignant neoplasms.

In a total of 601 staging rigid esophagoscopies that were performed in 582 patients, there were 9 complications, including 1 esophageal perforation.

The procedure had to be aborted in 50 cases. Among the remaining 551 completed esophagoscopies, the researchers found no abnormal findings in 523 patients, and nonmalignant pathologic findings were identified in 28 patients.

RELATED: Relatives of Patients With Carcinoma of Unknown Primary at Increased Risk

Incidence of synchronous esophageal malignant neoplasms upon literature review and SEER data analysis was found to be very low and has decreased from 1980 to 2010 in North America.

“Screening esophagoscopy should be limited to patients with HNSCC who are at high risk for synchronous esophageal malignant neoplasms,” the authors concluded.

Reference

  1. McGarey Jr PO, O'Rourke AK, Owen SR, et al. Rigid esophagoscopy for head and neck cancer staging and the incidence of synchronous esophageal malignant neoplasms [published online ahead of print December 3, 2015]. JAMA Otolaryngol Head Neck Surg. doi: 10.1001/jamaoto.2015.2815.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters